Yunnan Baiyao Group

Yunnan Baiyao Group Co., Ltd
SZSE: 000538
IndustryPharmaceutical
Headquarters
Kunming
,
China
RevenueRMB 22.6 billion (2016)[1]
WebsiteWebsite

Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products (mainly traditional Chinese medicine) and the wholesale and retail of pharmaceutical products.[2]

The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species".[3]

As of 2024 state, individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares.[4]

  1. ^ "Yunnan Baiyao Group Co. Ltd. A". Wall Street Journal.
  2. ^ Schuman, Michael (23 August 2017). "How One Company Brought Traditional Chinese Medicine To The Modern World And Made Billions". Forbes. Retrieved 13 September 2017.
  3. ^ "Yunnan Baiyao Group Co Ltd". 21 December 2021.
  4. ^ "While individual investors own 29% of Yunnan Baiyao Group Co". SimplyWall. Archived from the original on 2024-03-29. Retrieved 2024-03-29.